ვიტამინ „C“-ს გამოყენება ბაქტერიული ვაგინოზის მკურნალობის პროცესში

KONSTANTINE KHARABADZE; ZAZA BOKHUA; DAVID KOBESHAVIDZE

doi:10.52340/jecm.2026.02.05

Authors

KONSTANTINE KHARABADZE Tbilisi State Medical University
ZAZA BOKHUA Tbilisi State Medical University
DAVID KOBESHAVIDZE Tbilisi State Medical University

DOI:

https://doi.org/10.52340/jecm.2026.02.05

Keywords:

vitamin C, bacterial vaginosis, treatment

Abstract

Active detection of bacterial vaginosis (BV) during the first prenatal visit led to the formation of two clinical groups. Pregnant women in Group I (control group, n = 34) were treated according to the standard regimen (clindamycin + Gynoflor). In Group II (main group, n = 48), the same treatment regimen was supplemented with a vaginal form of vitamin C administered for 6 days.

Comparative analysis revealed the following: a) More frequent improvement in clinical and laboratory parameters in Group II; b) A lower recurrence rate of BV in Group II, manifested by a prolonged absence of complaints, persistently low vaginal pH, and sustained negative amine test results; c) A reduced risk of preterm labor in Group II.

These findings are presumably associated with firm preservation of the normal vaginal ecosystem induced by the vaginal application of vitamin C.

Downloads

Download data is not yet available.

References

Atashili j. et al., Bacterial vaginosis and HIV acquisition: a metaanalysis of publ. studies. AIDS. 2008; 22:1493-1501.

Crane j. M.G., Mogee L.A., et al. Maternal and perinatal outcomes of pregnancies delivered at 23 weeks` gestation. „j. Obstet. Gynecol. Can“ 2015; 37:214-24

Goldenberg R. j. et al. Epidemiology and causes of preterm birth. „Lancet“, 2008; 371 (9606): 75-84.

Khaikin Y., Elangainesan P., et al. Intravaginal Vitamin C for the Treatment and Prevention of Bacterial Vaginosis: Systematic Review and Meta-analysis. „Obstet. Gynecol.“, 2025 (ahead of print).

Krasnopolsky VN., Prilepskaya VN., et al. Efficacy of vitamin c vaginal tablets as prophylaxis for recurrent bacterial vaginosis: a randomized, double-blind, placebo-controlled clinical trial. „j. Clin. Med. Rev.“, 2013; 5(4): 309-315.

Mercer B.M. Preterm premature rupture of the membranes. „Obstet. Gynecol“, 2003; 101:178-93.

Ozkinay E., Terek M.C., et al. The effectiveness of live lactobacilli in combination with low dose estriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG, 2005;112(2):234-40.

Petersen E.E., Genet M., et al. Efficacy of Vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomized, double-blind, placebo-controlled clinical trial. „Arzneimittelforschung“, 2011; 61(4): 260-265.

Santiago G., Grob P., et al. Susceptibility testing of Atopobium vaginae for dequalinium chloride. BMC Res. Notes. 2012;5:151.

Sobei j. Bacterial vaginosis: treatment. Up To Date; 2014.

The cervix, vagina, vulva, physiology, pathology, colposcopy, aesthetic correction: a guide for practitioners; Edited by S.I. Rogovskaya, E.V. Lipova. Moscow: publishing house of the journal status Praesens; 2014, 250p.

Van de Wilgert j. H., Morison C.S., et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing; increase HIVI acquisition in African women. „J. Acquir. Immune. Defc. Syndr.“ 2008;48:203-209.

Weisseabacher E.R., Donders G., et al. A comparsion of dequalinium chloride vaginal tablets (Fluomizin) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety. „Gynecol. Obstet. Invest.“ 2012; 73(1):8-15.